ライフサイエンスコーパス: cumulative incidence rate

1 Cumulative incidence rate/100,000 population (CIR) of ne

2 val, 33-37) and 8751 readmissions at 1 year (cumulative incidence rate, 185 readmissions/100 patients

3 thout SVR experienced liver failure (10-year cumulative incidence rate, 2.1%; 95% CI, 0.0%-4.5%; vs 2

4 2005 readmissions during the first 30 days (cumulative incidence rate, 35 readmissions/100 patients;

5 nd 76 without SVR who developed HCC (10-year cumulative incidence rate, 5.1%; 95% CI, 1.3%-8.9%; vs 2

6 Cumulative incidence rates among treated and untreated p

7 We estimated the cumulative incidence rate and used Cox proportional haza

8 analysis was used to compute the unadjusted cumulative incidence rates and adjusted relative risks o

9 The estimated cumulative incidence rates at 20 years for any second ma

10 The estimated 5-year cumulative incidence rates by failure category were: tot

11 With median 58 months' follow-up, 4-year cumulative incidence rate (CIR) for AML/MDS was 2.55% +/

12 Cumulative incidence rates (CIRs) of >/= grade 3 cervica

13 63 patients with HR-positive disease, 8-year cumulative incidence rates comparing trastuzumab versus

14 Three-year cumulative incidence rates for any local, regional, or d

15 We calculated cumulative incidence rates for invasive pneumococcal dis

16 here was a decline (P<0.001) in NMSC 10-year cumulative incidence rate in RTRs over the period 1994-2

17 frequent in the chlorambucil arm with 6-year cumulative incidence rate of 20.6% versus 3.7% in the fl

18 The cumulative incidence rate of a second primary malignancy

19 Cumulative incidence rate of first alcohol relapse was 2

20 The 10-year cumulative incidence rate of liver-related mortality or

21 The 8-year cumulative incidence rate of secondary malignancies was

22 The cumulative incidence rate of secondary sarcoma was radia

23 The cumulative incidence rate of serious infections was 1.45

24 The annual cumulative incidence rate of uveitis ranged from 102.2 t

25 benchmark case was established by utilizing cumulative incidence rates of agranulocytosis from a rec

26 The cumulative incidence rates of all-cause death were not s

27 5-, 10-, 15-, and 20-year cumulative incidence rates of cardiac events were 2.2%,

28 g a former POW was associated with increased cumulative incidence rates of chronic disorders of the p

29 eveloping colorectal cancer (CRC), since the cumulative incidence rates of CRC in IBD-patients diagno

30 The 6-month, 1-year, and 10-year cumulative incidence rates of developing an NPM after st

31 Cumulative incidence rates of fractures were calculated

32 Cumulative incidence rates of grade 2 to 4 acute GVHD at

33 a history of subclinical social phobia, the cumulative incidence rates of heavy drinking and alcohol

34 In the R0 surgery-alone arm, the cumulative incidence rates of local recurrence at 5 and

35 By 3 years, the cumulative incidence rates of mortality and readmission

36 The 3-month, 6-month, and 1-year cumulative incidence rates of NPM after diagnosis of sta

37 The 30-year cumulative incidence rates of peripheral arterial events

38 Cumulative incidence rates of persistent nonadherence (i

39 recurrent MI modeled as competing risks, the cumulative incidence rates of post-MI HF among patients

40 ateral or bilateral intermediate AMD, 5-year cumulative incidence rates of progression to advanced AM

41 e versus placebo or observation, whereas the cumulative incidence rates of progression, death, or dea

42 The cumulative incidence rates of proven or probable invasiv

43 The cumulative incidence rates of relapse and treatment-rela

44 Cumulative incidence rates of second malignancies were c

45 The cumulative incidence rates of serious infections are rep

46 n-Meier analyses, we calculated age-adjusted cumulative incidence rates of stroke.

47 The cumulative incidence rates of sudden death were assessed

48 Overall cumulative incidence rates of symptomatic VTEs were 15.1

49 Cumulative incidence rate ratios (IRRs) for treated vers

50 In 35 patients who could be evaluated, the cumulative incidence rate (+/-SE) of grade II to IV acut

51 The cumulative incidence rate was 2.2 percent (95 percent co

52 reated in 1307 women (2.2%), and the 10-year cumulative incidence rate was 3.29 (95% CI, 3.05-3.53).

53 57 patients with HR-negative disease, 8-year cumulative incidence rates were 24.0% versus 33.4% (P <

54 Ten-year cumulative incidence rates were 3% for renal replacement

55 Cumulative incidence rates were 5.1% (95% confidence int

56 Cumulative incidence rates were as follows: pediatric AH

57 Cumulative incidence rates were calculated for each year

58 Cumulative incidence rates were calculated using competi

59 Cumulative incidence rates were calculated using competi

60 Cumulative incidence rates were virtually identical for

61 or MI or stroke were compared with estimated cumulative incidence rates with inverse probability weig